Events

6th CKD Summit – Chronic Kidney Disease Drug Development

19-21 March, 2024
Boston, MA

ENYO Pharma will attend the 6th Chronic Kidney Disease Drug Development Summit, an industry forum sharing cross-industry insight to bring effective therapies to patients suffering from kidney diseases expanding also to rare renal disorders.

https://ckd3-summit.com/

Read more »

The 2024 international workshop on Alport syndrome

14-16 March, 2024 – Nicosia, Cyprus
ENYO Pharma is sponsoring and will attend The 2024 International Workshop on Alport syndrome organized by the Alport Syndrome Alliance, an international patient-driven collaboration.

ASN Kidney Week

2-5 November 2023
Philadelphia, PA

ENYO Pharma will attend the world’s premier nephrology meeting of the American Society of Nephrology, ASN Kidney Week
https://www.asn-online.org/education/kidneyweek/

Read more »

Alport Connect 2023, the annual Alport syndrome patient and family meeting in US

7-8 October, 2023
San Diego, CA

ENYO Pharma is sponsoring and will attend Alport Connect 2023 organized by the American Alport Syndrome Foundation (ASF) to meet patients and their family and present its Phase 2 clinical study planned with Vonafexor in Alport syndrome patients.

Alport Connect Meetings

Read more »

60th ERA congress, the Annual Nephrology Congress in Europe

15-18 June 2023
Milan, Italy

ENYO Pharma will attend and present at 60th ERA congress, the Annual Nephrology Congress in Europe
https://www.era-online.org/en/milan2023/

Read more »